Odd Lilleng Gammelgaard

Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer

Carla L. Alves, Sidse Ehmsen, Mikkel G. Terp et al. · Nature Communications · 2021 · 84 citations · Full text

Medicine, Oncology, Pharmacology +17

Human cancer evolution in the context of a human immune system in mice

Odd Lilleng Gammelgaard, Mikkel G. Terp, Birgitte Preiss et al. · Molecular Oncology · 2018 · 28 citations · Full text

Medicine, Immunology, Oncology +17

Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity

Odd Lilleng Gammelgaard, Mikkel G. Terp, Christian Renn et al. · Journal for ImmunoTherapy of Cancer · 2022 · 23 citations · Full text

Medicine, Immunology, Oncology +17

DNA methyltransferase inhibition promotes recruitment of myeloid-derived suppressor cells to the tumor microenvironment through induction of tumor cell-intrinsic interleukin-1

Sofie Traynor, Mikkel G. Terp, Aaraby Nielsen et al. · Cancer Letters · 2022 · 20 citations · Full text

Medicine, Oncology, Pharmacology +14

PDX Models: A Versatile Tool for Studying the Role of Myeloid-Derived Suppressor Cells in Breast Cancer

Morten F. Gjerstorff, Sofie Traynor, Odd Lilleng Gammelgaard et al. · Cancers · 2022 · 17 citations · Full text

Medicine, Immunology, Oncology +17